Influenza A and influenza B are the two types of flu virus responsible for seasonal outbreaks each year. Both cause the same familiar symptoms (fever, cough, body aches, fatigue) and can lead to equally serious illness, including hospitalization and death. The real differences lie in how the viruses behave behind the scenes: how quickly they mutate, what species they infect, and whether they can trigger a global pandemic.
How the Two Viruses Are Built Differently
Influenza A is far more genetically diverse. It’s classified into subtypes based on two surface proteins, and there are 18 versions of one and 11 of the other. That creates a huge number of possible combinations, with more than 130 already identified in nature, mostly in wild birds. This diversity is what makes influenza A unpredictable. It can swap genetic material between subtypes in a process called reassortment, occasionally producing a strain so different from previous ones that almost nobody has immunity to it.
Influenza B has no subtypes at all. Instead, it splits into just two lineages: B/Victoria and B/Yamagata. It also mutates more slowly than influenza A, particularly compared to the A(H3N2) subtype, which is one of the fastest-changing flu viruses. This slower rate of change means your immune system has a somewhat easier time recognizing influenza B from year to year.
Why Only Flu A Causes Pandemics
Influenza A is the only flu virus capable of causing pandemics. The reason ties directly to its biology. Because it infects birds, pigs, and other animals in addition to humans, it has a massive reservoir of genetic diversity to draw from. When a bird flu strain mixes with a human flu strain inside a shared host like a pig, the result can be a completely novel virus that spreads easily among people who have no existing protection against it. That’s how the 1918, 1957, 1968, and 2009 pandemics all started.
Influenza B circulates almost exclusively in humans. Without that animal reservoir feeding it new genetic material, it simply can’t reinvent itself dramatically enough to spark a pandemic. It still causes widespread seasonal illness, but the scale stays within the bounds of a normal flu season.
Symptom Severity Is Surprisingly Similar
Many people assume flu A is always “worse” than flu B, but the clinical data doesn’t support that. A CDC study comparing hospitalized adults with flu A and flu B infections found no significant difference in how severe the illness was. Length of hospital stay, the proportion of patients admitted to intensive care, and the proportion of deaths were all comparable between the two virus types.
The symptoms themselves are essentially identical: sudden fever, chills, cough, sore throat, muscle aches, headache, and fatigue. There’s no reliable way to tell which type you have based on how you feel. A diagnostic test is the only way to distinguish them.
Children Face Higher Risk From Flu B
One area where the two viruses do diverge is their impact on kids. Influenza B causes significant illness and complications in children at rates that are disproportionately high compared to adults. During some flu seasons, influenza B accounts for a larger share of pediatric hospitalizations than you’d expect given its overall circulation. This is one reason public health officials emphasize flu vaccination for children every year, regardless of which type is predicted to dominate.
Testing Can Tell Them Apart
Rapid flu tests, the kind you’d get at an urgent care or doctor’s office, can identify whether you have influenza A, influenza B, or neither. These tests must meet FDA standards of at least 80% sensitivity for detecting both types when compared against the gold-standard lab method (RT-PCR), and at least 95% specificity. In practical terms, a positive result is very reliable, but a negative result doesn’t completely rule out the flu, especially early in illness when viral levels may be low.
Knowing which type you have can matter for treatment decisions, since one antiviral medication performs notably better against flu B than others.
Treatment Options Overlap, With One Key Difference
The main antiviral medications work against both influenza A and B. Three of them belong to the same drug class and block a protein the virus needs to spread from cell to cell. A newer option, baloxavir (Xofluza), works through a different mechanism and is also active against both types.
Where things get interesting is with flu B specifically. In a randomized controlled trial, baloxavir reduced the time to symptom improvement by more than 24 hours compared to the older standard antiviral in patients with influenza B. For flu A, the two treatments performed more similarly. So if you test positive for flu B, your doctor may have a reason to choose one antiviral over another.
An older class of antiviral drugs (amantadine and rimantadine) only ever worked against influenza A, and even that is no longer the case. Resistance among circulating flu A viruses is now so high that these medications are no longer recommended for treatment or prevention.
How the Flu Vaccine Covers Both Types
For the 2024-2025 season, all flu vaccines used in the United States are trivalent, meaning they protect against three strains: two influenza A subtypes (H1N1 and H3N2) and one influenza B lineage (B/Victoria). This is a change from previous years, when vaccines were quadrivalent and included both B lineages.
The shift happened because the B/Yamagata lineage appears to have gone extinct. No B/Yamagata viruses have been detected anywhere in the world since March 2020, now five consecutive seasons without a single confirmed case. Every circulating influenza B virus that researchers have been able to characterize belongs to the B/Victoria lineage. The FDA recommended dropping the Yamagata component starting with the 2024-2025 season, and that recommendation continues for 2025-2026.
This means the practical landscape has simplified. Where there were once four flu threats to vaccinate against, there are now effectively three: two influenza A subtypes that keep shifting and one influenza B lineage that changes more slowly but still packs a serious punch, especially for children.